Regeneron Pharmaceuticals (NQ:REGN)Price and VolumeDetailed Quote
Top NewsMore News
Performance
52-Week Range
6.3% below 52-week high
805.02
572.7552W Low
859.3452W High
1 Week
2.5% below 1-week high
780.831W Low
825.521W High
Regeneron Pharmaceuticals (REGN) traded between $572.75 and $859.34 over the past 52 weeks and last traded at $805.02, 6.3% below its 52-week high. Over the past week it ranged between $780.83 and $825.52.
Past 12 Months
+2.9%
+0.4%
+22.7%
+7.1%
+3.7%
+39.8%
1W
+$22.98
1M
+$3.20
3M
+$149.01
6M
+$53.45
YTD
+$28.71
1Y
+$229.33
REGN was +39.8% over the past year, +7.1% over six months, +3.7% year to date, +2.9% in the last week.
12 Months vs Market
REGN
DIA
SPY
QQQ
IWM
Over the past 12 months REGN returned +39.8% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
0.72× 3-mo avg
Today 527,740
3-mo avg 732.1K
1W
1M
3M
6M
YTD
1Y
REGN most recently traded 527,740 shares against a 3-month average daily volume of 732.1K. More NewsRead More
Q2 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
October 14, 2026
Via StockStory
Topics
Artificial Intelligence
Top S&P500 movers in Wednesday's session ↗
October 14, 2026
Via Chartmill
Discover which S&P500 stocks are making waves on Monday. ↗
October 12, 2026
Via Chartmill
Why Regeneron (REGN) Stock Is Trading Lower Today
October 01, 2026
Via StockStory
Which S&P500 stocks are moving on Thursday? ↗
October 01, 2026
Via Chartmill
Regeneron, Sanofi Expand Alliance in Deal Worth Up to $8 Billion ↗
October 01, 2026
Via MarketBeat
Topics
ETFs
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
September 30, 2026
Via StockStory
Topics
Artificial Intelligence
Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30? ↗
September 28, 2026
Via The Motley Fool
1 Profitable Stock with Impressive Fundamentals and 2 That Underwhelm
September 28, 2026
Via StockStory
Via MarketBeat
Topics
ETFs
Is Regeneron Stock a Bargain Below $800? ↗
September 22, 2026
Via The Motley Fool
Topics
Intellectual Property
1 S&P 500 Stock Worth Your Attention and 2 We Ignore
September 22, 2026
Via StockStory
Topics
Stocks
Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum ↗
September 14, 2026
Via MarketBeat
Topics
Intellectual Property
Frequently Asked QuestionsIs Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 805.02
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 10/23/26 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 73.88B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 74B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>